{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T11:19:38Z","timestamp":1720696778628},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00066-010-2178-2","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T19:35:06Z","timestamp":1294947306000},"page":"15-22","source":"Crossref","is-referenced-by-count":27,"title":["Feasibility, Toxicity, and Efficacy of Short Induction Chemotherapy of Docetaxel Plus Cisplatin or Carboplatin (TP) Followed by Concurrent Chemoradio \u00ad therapy for Organ Preservation in Advanced Cancer of the Hypopharynx, Larynx, and Base of Tongue","Durchf\u00fchrbarkeit, Toxizit\u00e4t und Effektivit\u00e4t der Kurzinduktionschemotherapie mit Docetaxel und Cisplatin oder Carboplatin (TP) vor Radiochemotherapie (RCT) zum Organerhalt bei Patienten mit Hypopharynx-, Larynx- und Zungengrundkarzinomen \u2013 Erste Ergebnisse"],"prefix":"10.1007","volume":"187","author":[{"given":"Sabine","family":"Semrau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Waldfahrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Linke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunther","family":"Klautke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kuwert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Uder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Iro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"2178_CR1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0360-3016(02)02816-X","volume":"53","author":"Abitbol","year":"2002","unstructured":"Abitbol A, Abdel-Wahab M, Lewin A, et al. A phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and\/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. Int J Radiat Oncol Biol Phys 2002;53:942\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2178_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hed.21179","volume":"32","author":"Adelstein","year":"2010","unstructured":"Adelstein DJ, Moon J, Hanna E, et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation\/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). Head Neck 2010;32:221\u20138.","journal-title":"Head Neck"},{"key":"2178_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00066-010-2082-9","volume":"186","author":"Berger","year":"2010","unstructured":"Berger B, Belka C, Weinmann M, et al. Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol 2010;186:255\u201361.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR4","first-page":"24","volume":"2006","author":"Calais","year":"2006","unstructured":"Calais G, Pointreau I, Alfons M, et al. Randomized phase III trial comparing induction chemotherapy using cisplatin, fluorouracil, with or without docetaxel for organpreservation in hypopharynx and larynx cacer. Preliminary results of the GORTEC 2000\u201301. ASCO Annual Meeting Proc 2006;24:5506.","journal-title":"ASCO Annual Meeting Proc"},{"key":"2178_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2008.11.041","volume":"75","author":"Dirix","year":"2009","unstructured":"Dirix P, Abbeel S, Vanstraelen B, et al. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75:385\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2178_CR6","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091\u20138.","journal-title":"N Engl J Med"},{"key":"2178_CR7","first-page":"5517","volume":"24","author":"Forastiere","year":"2006","unstructured":"Forastiere AA, Maor M, Weber RS, et al. Long-term results of Intergroup RTOG 91-11: phase III trial to preserve the larynx-induction cisplatin\/5-FU and radiation therapy vs. concurrent cisplatin and radiation therapy vs. radiation therapy. ASCO Annunal Meeting Proc 2006;24:5517.","journal-title":"ASCO Annunal Meeting Proc"},{"key":"2178_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/PL00002330","volume":"176","author":"Hesse","year":"2000","unstructured":"Hesse K, Heinrich B, Zimmermann F, et al. Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors. Strahlenther Onkol 2000;176:67\u201372.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR9","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","volume":"23","author":"Hitt","year":"2005","unstructured":"Hitt R, L\u00f3pez-Pousa A, Mart\u00ednez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005;23:8636\u201345.","journal-title":"J Clin Oncol"},{"key":"2178_CR10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1385\/MO:23:3:325","volume":"23","author":"Kuhnt","year":"2006","unstructured":"Kuhnt T, Becker A, Bloching M, et al. Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors. Med Oncol 2006;23:325\u201333.","journal-title":"Med Oncol"},{"key":"2178_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00066-003-1106-0","volume":"179","author":"Kuhnt","year":"2003","unstructured":"Kuhnt T, Becker A, Pigorsch S, et al. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I\u2013II trial. Strahlenther Onkol 2003;179:673\u201381.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","volume":"88","author":"Lefebvre","year":"1996","unstructured":"Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2178_CR13","first-page":"5531","volume":"22","author":"Lefebvre","year":"2004","unstructured":"Lefebvre JL, Chevalier D, Luboinski B, et al. Is laryngeal preservation (LP) with induction chemotherapy (ICT) safe in the treatment of hypopharyngeal SCC. Final results of the EORTC 24891 trial, ASCO Annunal Meeting Pro 2004;22:5531.","journal-title":"ASCO Annunal Meeting Pro"},{"key":"2178_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2007.07.009","volume":"85","author":"Levendag","year":"2007","unstructured":"Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007;85:64\u201373.","journal-title":"Radiother Oncol"},{"key":"2178_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00066-009-1967-y","volume":"185","author":"Olthoff","year":"2009","unstructured":"Olthoff A, Ewen A, Wolff HA, et al. Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 2009;185:303\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00001813-200404000-00004","volume":"15","author":"Pignon","year":"2004","unstructured":"Pignon JP, Syz N, Posner M, et al. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck. Anticancer Drugs 2004;15:331\u201340.","journal-title":"Anticancer Drugs"},{"key":"2178_CR17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Pointreau","year":"2009","unstructured":"Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009;101:498\u2013506.","journal-title":"J Natl Cancer Inst"},{"key":"2178_CR18","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"Posner","year":"2007","unstructured":"Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705\u201315.","journal-title":"N Engl J Med"},{"key":"2178_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdn752","volume":"20","author":"Posner","year":"2009","unstructured":"Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 2009;20:921\u20137.","journal-title":"Ann Oncol"},{"key":"2178_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00066-009-1989-5","volume":"185","author":"Steinmann","year":"2009","unstructured":"Steinmann D, Cerny B, Karstens JH, et al. Chemoradiotherapy with weekly cisplatin 40 mg\/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol 2009;185:682\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR21","doi-asserted-by":"crossref","unstructured":"The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685\u201390.","DOI":"10.1056\/NEJM199106133242402"},{"key":"2178_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00066-009-1992-x","volume":"185","author":"Tribius","year":"2009","unstructured":"Tribius S, Kronemann S, Kilic Y, et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675\u201381.","journal-title":"Strahlenther Onkol"},{"key":"2178_CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2005.01.2047","volume":"24","author":"Urba","year":"2006","unstructured":"Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 2006;24:593\u20138.","journal-title":"J Clin Oncol"},{"key":"2178_CR24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"Vermorken","year":"2007","unstructured":"Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695\u2013704.","journal-title":"N Engl J Med"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2178-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2178-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:48:48Z","timestamp":1712112528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2178-2"}},"subtitle":["Early Results"],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2178-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}